94 related articles for article (PubMed ID: 32167614)
1. Clinical role of combining alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein for hepatocellular carcinoma: Evidence from literature and an original study.
Chen S; Li J; Tan X; Xu Q; Mo Y; Qin H; Zhou L; Ma L; Wei Z
J Clin Lab Anal; 2020 Jul; 34(7):e23262. PubMed ID: 32167614
[TBL] [Abstract][Full Text] [Related]
2.
Lee HA; Lee YR; Lee YS; Jung YK; Kim JH; An H; Yim HJ; Jeen YT; Yeon JE; Byun KS; Seo YS
World J Gastroenterol; 2021 Jul; 27(28):4687-4696. PubMed ID: 34366629
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma.
Kumada T; Toyoda H; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tanaka J; Kagebayashi C; Satomura S
J Gastroenterol; 2014 Mar; 49(3):555-63. PubMed ID: 24057163
[TBL] [Abstract][Full Text] [Related]
4. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States.
Tayob N; Kanwal F; Alsarraj A; Hernaez R; El-Serag HB
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):415-423.e4. PubMed ID: 35124267
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Mao Y
Biomed Res Int; 2017; 2017():5358615. PubMed ID: 28540298
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma.
Fu J; Li Y; Li Z; Li N
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29717027
[TBL] [Abstract][Full Text] [Related]
7. Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.
Xu D; Su C; Sun L; Gao Y; Li Y
Ann Hepatol; 2019; 18(1):58-67. PubMed ID: 31113610
[TBL] [Abstract][Full Text] [Related]
8. Intramolecular fluorescence resonance energy transfer strategy for accurate detection of AFP-L3% and improved diagnosis of hepatocellular carcinoma.
Liu Y; Han G; Gong J; Hua X; Zhu Q; Zhou S; Jiang L; Li Q; Liu S
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122950. PubMed ID: 37295202
[TBL] [Abstract][Full Text] [Related]
9. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.
Hanif H; Ali MJ; Susheela AT; Khan IW; Luna-Cuadros MA; Khan MM; Lau DT
World J Gastroenterol; 2022 Jan; 28(2):216-229. PubMed ID: 35110946
[TBL] [Abstract][Full Text] [Related]
10. The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma.
Olbrich A; Niemeyer J; Seiffert H; Ebel S; Gros O; Lordick F; Forstmeyer D; Seehofer D; Rademacher S; Denecke T; Matz-Soja M; Berg T; van Bömmel F
J Cancer Res Clin Oncol; 2024 Feb; 150(2):81. PubMed ID: 38319485
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of serum derived exosomes for hepatocellular carcinoma: a systematic review and meta-analysis.
Tiyuri A; Baghermanesh SS; Davatgaran-Taghipour Y; Eslami SS; Shaygan N; Parsaie H; Barati M; Jafari D
Expert Rev Mol Diagn; 2023; 23(11):971-983. PubMed ID: 37715364
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.
Butaye E; Somers N; Grossar L; Pauwels N; Lefere S; Devisscher L; Raevens S; Geerts A; Meuris L; Callewaert N; Van Vlierberghe H; Verhelst X
Aliment Pharmacol Ther; 2024 Jan; 59(1):23-38. PubMed ID: 37877758
[TBL] [Abstract][Full Text] [Related]
13. Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
Liver Cancer; 2015 Mar; 4(2):126-36. PubMed ID: 26020034
[TBL] [Abstract][Full Text] [Related]
14. Development of lectin-based lateral flow assay for fucosylated alpha-fetoprotein.
Puangpila C; Anukulkich N; Chiapleam S; Intajan B; Jakmunee J; Pencharee S
J Cell Biochem; 2023 Oct; 124(10):1546-1556. PubMed ID: 37665725
[TBL] [Abstract][Full Text] [Related]
15. If AFP is elevated, where is cancer? The case report on hereditary persistence of Alpha-fetoprotein.
Saracoglu H; Baskol M; Saracoglu H; Baskol G
Malawi Med J; 2022 Dec; 34(4):291-293. PubMed ID: 38125776
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the GALAD model for diagnosing primary hepatocellular carcinoma.
Lu JL; Yuan XY; Zhang JS; Li Y
Technol Health Care; 2024 May; ():. PubMed ID: 38759033
[TBL] [Abstract][Full Text] [Related]
17. Lysosomes Initiating and DNAzyme-Assisted Intracellular Signal Amplification Strategy for Quantification of Alpha-Fetoprotein in a Single Cell.
Chen S; Zhao J; Xu C; Shi B; Xu J; Hu S; Zhao S
Anal Chem; 2024 Jan; 96(1):85-91. PubMed ID: 38128902
[TBL] [Abstract][Full Text] [Related]
18. Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.
Ma C; Jin Y; Wang Y; Xu H; Zhang J
Front Oncol; 2023; 13():1231420. PubMed ID: 37781207
[TBL] [Abstract][Full Text] [Related]
19. SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE.
Andrighetto LV; Poziomyck AK
Arq Bras Cir Dig; 2016; 29(4):276-278. PubMed ID: 28076486
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
